ATOMO DIAGNOSTICS LIMITED - Announcements

Market Cap $15.98M Add to my watchlist

Healthcare Medical Devices

Atomo Diagnostics Limited is an Australia-based medical device company. The Company... Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AT1	Notification of cessation of securities - AT1		02/09/22	21.62KB	Share
AT1	2022 Appendix 4G and Corporate Governance Statement		25/08/22	726.19KB	Share
AT1	Investor Webinar and Presentation		25/08/22	2.82MB	Share
AT1	2022 Appendix 4E and Annual Report	PRICE SENSITIVE	25/08/22	1.25MB	Share
AT1	COVID RAT Supply Agreement signed with AllTest & TGA Update		22/08/22	164.59KB	Share
AT1	Quarterly Activity Report - 30 June 2022	PRICE SENSITIVE	29/07/22	233.27KB	Share
AT1	Appendix 4C - 30 June 2022	PRICE SENSITIVE	29/07/22	830.13KB	Share
AT1	Change in substantial holding		14/07/22	210.49KB	Share
AT1	Change in substantial holding		27/05/22	208.9KB	Share
AT1	Cleansing Statement		06/05/22	151.39KB	Share
AT1	Application for quotation of securities - AT1		03/05/22	25.66KB	Share
AT1	Notification regarding unquoted securities - AT1		29/04/22	33.69KB	Share
AT1	Quarterly Activity Report - 31 March 2022	PRICE SENSITIVE	27/04/22	198.58KB	Share
AT1	Appendix 4C - 31 March 2022	PRICE SENSITIVE	27/04/22	874.38KB	Share
AT1	Notification of cessation of securities - AT1		26/04/22	21.6KB	Share
AT1	Atomo expands executive team		26/04/22	101.99KB	Share
AT1	Application for quotation of securities - AT1		19/04/22	24.26KB	Share
AT1	Change of Director's Interest Notice - J Keith		13/04/22	284.82KB	Share
AT1	Change of Director's Interest Notice - C LaBelle		13/04/22	288.71KB	Share
AT1	Notification of cessation of securities - AT1		13/04/22	21.71KB	Share
AT1	Release of Securities from Escrow		08/04/22	132.05KB	Share
AT1	Pac Partners Healthcare Conference Presentation		06/04/22	1.2MB	Share
AT1	ASX Small and Mid-Cap Conference Presentation		16/03/22	1.18MB	Share
AT1	Investor Presentation	PRICE SENSITIVE	21/02/22	1.33MB	Share
AT1	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	21/02/22	784.26KB	Share
AT1	Atomo H1 FY22 Results Investor Briefing		18/02/22	133.01KB	Share
AT1	Atomo receives approval for its COVID-19 antigen test in NZ	PRICE SENSITIVE	27/01/22	145.2KB	Share
AT1	Change of Company Secretary		25/01/22	112.76KB	Share
AT1	Quarterly Activity Report - 31 December 2021	PRICE SENSITIVE	25/01/22	266.99KB	Share
AT1	Appendix 4C - 31 December 2021	PRICE SENSITIVE	25/01/22	808.99KB	Share
AT1	Investor Briefing - Q2 FY22 Results		24/01/22	119.42KB	Share
AT1	Response to ASX Price Query	PRICE SENSITIVE	30/12/21	242.7KB	Share
AT1	Appendix 3Z		10/12/21	148.17KB	Share
AT1	Board Changes		09/12/21	84.05KB	Share
AT1	Change in substantial holding		26/11/21	208.74KB	Share
AT1	Relocation of head office		25/11/21	115.61KB	Share
AT1	Investor Presentation		10/11/21	1.42MB	Share
AT1	Appendix 3Y - J Kelly		08/11/21	162.26KB	Share
AT1	Notification regarding unquoted securities - AT1		08/11/21	29.92KB	Share
AT1	Results of the AGM		28/10/21	171.06KB	Share
AT1	Ceasing to be a substantial holder		28/10/21	81.85KB	Share
AT1	Chairman's AGM Address		28/10/21	161.97KB	Share
AT1	Managing Director's AGM Presentation		28/10/21	1.05MB	Share
AT1	HIV Self-Test - improved supply & advertising conditions	PRICE SENSITIVE	26/10/21	124.29KB	Share
AT1	Quarterly Activity Report - 30 September 2021	PRICE SENSITIVE	25/10/21	277.65KB	Share
AT1	Appendix 4C - 30 September 2021	PRICE SENSITIVE	25/10/21	776.92KB	Share
AT1	Appendix 4G & 2021 Corporate Governance Statement		05/10/21	536.46KB	Share
AT1	2021 Annual Report		05/10/21	4MB	Share
AT1	Atomo and Access Bio renegotiate supply agreements	PRICE SENSITIVE	05/10/21	103.23KB	Share
AT1	Trading Halt	PRICE SENSITIVE	04/10/21	193.15KB	Share
AT1	Pause in Trading	PRICE SENSITIVE	04/10/21	117.13KB	Share
AT1	Atomo 2021 Annual General Meeting		27/09/21	686.38KB	Share
AT1	Initial Director's Interest Notice		24/09/21	144.49KB	Share
AT1	Change in substantial holding		16/09/21	222.57KB	Share
AT1	Appointment of Independent Non-Executive Director		15/09/21	102.12KB	Share
AT1	Becoming a substantial holder		14/09/21	90.44KB	Share
AT1	Investor Webinar		02/09/21	113.48KB	Share
AT1	Notification of date of 2021 AGM		01/09/21	94.87KB	Share
AT1	Notification of cessation of securities - AT1		31/08/21	21.71KB	Share
AT1	Notification of cessation of securities - AT1		31/08/21	21.7KB	Share
AT1	FY21 Results Investor Briefing		27/08/21	99.35KB	Share
AT1	FY21 Results Presentation	PRICE SENSITIVE	27/08/21	1.94MB	Share
AT1	Appendix 4E & Annual Financial Report	PRICE SENSITIVE	27/08/21	365.91KB	Share
AT1	Ceasing to be a substantial holder		11/08/21	409.53KB	Share
AT1	Investor Briefing - Quarterly Update		30/07/21	124.79KB	Share
AT1	Quarterly Activity Report - 30 June 2021	PRICE SENSITIVE	29/07/21	316.1KB	Share
AT1	Appendix 4C - 30 June 2021	PRICE SENSITIVE	29/07/21	874.74KB	Share
AT1	Change in substantial holding		01/07/21	813.88KB	Share
AT1	Access Bio receives FDA clearance for COVID-19 antibody test	PRICE SENSITIVE	28/06/21	229.77KB	Share
AT1	Proposed issue of Securities - AT1		30/04/21	26.58KB	Share
AT1	Proposed issue of Securities - AT1		30/04/21	26.58KB	Share
AT1	Update to Atomo's US market strategy	PRICE SENSITIVE	30/04/21	154.1KB	Share
AT1	Quarterly Activity Report & Appendix 4C - 31 March 2021	PRICE SENSITIVE	30/04/21	642.38KB	Share
AT1	Viatris & Atomo to Support Unitaid HIV Self-Test Expansion	PRICE SENSITIVE	29/04/21	219.48KB	Share
AT1	Appendix 3Y - C LaBelle		09/04/21	161.43KB	Share
AT1	Cleansing notice		09/04/21	195.72KB	Share
AT1	Appendix 3G		08/04/21	274.49KB	Share
AT1	Appendix 2A		08/04/21	277.68KB	Share
AT1	Atomo to present at NWR Virtual Investor Conference		17/03/21	141.85KB	Share
AT1	S&P DJI Announces March 2021 Quarterly Rebalance	PRICE SENSITIVE	12/03/21	183.24KB	Share
AT1	Investor Presentation		10/03/21	3.21MB	Share
AT1	Notification of release of escrowed shares		08/03/21	136.44KB	Share
AT1	Investor Presentation	PRICE SENSITIVE	23/02/21	2.81MB	Share
AT1	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	23/02/21	675.53KB	Share
AT1	H1 FY21 results investor briefing		19/02/21	134.79KB	Share
AT1	Quarterly Activity Report & Appendix 4C - 31 December 2020	PRICE SENSITIVE	27/01/21	697.41KB	Share
AT1	Atomo provides update on its HIV Rapid Test business	PRICE SENSITIVE	07/12/20	369.13KB	Share
AT1	Cleansing notice		26/11/20	342.2KB	Share
AT1	Appendix 3G		26/11/20	394.67KB	Share
AT1	Appendix 2A		25/11/20	406.87KB	Share
AT1	Cleansing notice		19/11/20	343KB	Share
AT1	Appendix 2A		18/11/20	406.89KB	Share
AT1	Atomo receives TGA approval for AtomoRapid HIV (1&2) test	PRICE SENSITIVE	10/11/20	355.89KB	Share
AT1	Results of the AGM		04/11/20	350.67KB	Share
AT1	Managing Director's AGM Presentation	PRICE SENSITIVE	04/11/20	1.6MB	Share
AT1	Chairman's AGM Address		04/11/20	330.87KB	Share
AT1	Atomo to present at virtual investor conference		03/11/20	230.16KB	Share
AT1	Cleansing notice		30/10/20	343.56KB	Share
AT1	Appendix 2A		29/10/20	408.31KB	Share
AT1	Quarterly Activity Report & Appendix 4C - 30 September 2020	PRICE SENSITIVE	29/10/20	768.95KB	Share

AT1 Notification of cessation of securities - AT1
02/09/22		21.62KB	Share
AT1 2022 Appendix 4G and Corporate Governance Statement
25/08/22		726.19KB	Share
AT1 Investor Webinar and Presentation
25/08/22		2.82MB	Share
AT1 2022 Appendix 4E and Annual Report
25/08/22	PRICE SENSITIVE	1.25MB	Share
AT1 COVID RAT Supply Agreement signed with AllTest & TGA Update
22/08/22		164.59KB	Share
AT1 Quarterly Activity Report - 30 June 2022
29/07/22	PRICE SENSITIVE	233.27KB	Share
AT1 Appendix 4C - 30 June 2022
29/07/22	PRICE SENSITIVE	830.13KB	Share
AT1 Change in substantial holding
14/07/22		210.49KB	Share
AT1 Change in substantial holding
27/05/22		208.9KB	Share
AT1 Cleansing Statement
06/05/22		151.39KB	Share
AT1 Application for quotation of securities - AT1
03/05/22		25.66KB	Share
AT1 Notification regarding unquoted securities - AT1
29/04/22		33.69KB	Share
AT1 Quarterly Activity Report - 31 March 2022
27/04/22	PRICE SENSITIVE	198.58KB	Share
AT1 Appendix 4C - 31 March 2022
27/04/22	PRICE SENSITIVE	874.38KB	Share
AT1 Notification of cessation of securities - AT1
26/04/22		21.6KB	Share
AT1 Atomo expands executive team
26/04/22		101.99KB	Share
AT1 Application for quotation of securities - AT1
19/04/22		24.26KB	Share
AT1 Change of Director's Interest Notice - J Keith
13/04/22		284.82KB	Share
AT1 Change of Director's Interest Notice - C LaBelle
13/04/22		288.71KB	Share
AT1 Notification of cessation of securities - AT1
13/04/22		21.71KB	Share
AT1 Release of Securities from Escrow
08/04/22		132.05KB	Share
AT1 Pac Partners Healthcare Conference Presentation
06/04/22		1.2MB	Share
AT1 ASX Small and Mid-Cap Conference Presentation
16/03/22		1.18MB	Share
AT1 Investor Presentation
21/02/22	PRICE SENSITIVE	1.33MB	Share
AT1 Appendix 4D and Half Year Financial Report
21/02/22	PRICE SENSITIVE	784.26KB	Share
AT1 Atomo H1 FY22 Results Investor Briefing
18/02/22		133.01KB	Share
AT1 Atomo receives approval for its COVID-19 antigen test in NZ
27/01/22	PRICE SENSITIVE	145.2KB	Share
AT1 Change of Company Secretary
25/01/22		112.76KB	Share
AT1 Quarterly Activity Report - 31 December 2021
25/01/22	PRICE SENSITIVE	266.99KB	Share
AT1 Appendix 4C - 31 December 2021
25/01/22	PRICE SENSITIVE	808.99KB	Share
AT1 Investor Briefing - Q2 FY22 Results
24/01/22		119.42KB	Share
AT1 Response to ASX Price Query
30/12/21	PRICE SENSITIVE	242.7KB	Share
AT1 Appendix 3Z
10/12/21		148.17KB	Share
AT1 Board Changes
09/12/21		84.05KB	Share
AT1 Change in substantial holding
26/11/21		208.74KB	Share
AT1 Relocation of head office
25/11/21		115.61KB	Share
AT1 Investor Presentation
10/11/21		1.42MB	Share
AT1 Appendix 3Y - J Kelly
08/11/21		162.26KB	Share
AT1 Notification regarding unquoted securities - AT1
08/11/21		29.92KB	Share
AT1 Results of the AGM
28/10/21		171.06KB	Share
AT1 Ceasing to be a substantial holder
28/10/21		81.85KB	Share
AT1 Chairman's AGM Address
28/10/21		161.97KB	Share
AT1 Managing Director's AGM Presentation
28/10/21		1.05MB	Share
AT1 HIV Self-Test - improved supply & advertising conditions
26/10/21	PRICE SENSITIVE	124.29KB	Share
AT1 Quarterly Activity Report - 30 September 2021
25/10/21	PRICE SENSITIVE	277.65KB	Share
AT1 Appendix 4C - 30 September 2021
25/10/21	PRICE SENSITIVE	776.92KB	Share
AT1 Appendix 4G & 2021 Corporate Governance Statement
05/10/21		536.46KB	Share
AT1 2021 Annual Report
05/10/21		4MB	Share
AT1 Atomo and Access Bio renegotiate supply agreements
05/10/21	PRICE SENSITIVE	103.23KB	Share
AT1 Trading Halt
04/10/21	PRICE SENSITIVE	193.15KB	Share
AT1 Pause in Trading
04/10/21	PRICE SENSITIVE	117.13KB	Share
AT1 Atomo 2021 Annual General Meeting
27/09/21		686.38KB	Share
AT1 Initial Director's Interest Notice
24/09/21		144.49KB	Share
AT1 Change in substantial holding
16/09/21		222.57KB	Share
AT1 Appointment of Independent Non-Executive Director
15/09/21		102.12KB	Share
AT1 Becoming a substantial holder
14/09/21		90.44KB	Share
AT1 Investor Webinar
02/09/21		113.48KB	Share
AT1 Notification of date of 2021 AGM
01/09/21		94.87KB	Share
AT1 Notification of cessation of securities - AT1
31/08/21		21.71KB	Share
AT1 Notification of cessation of securities - AT1
31/08/21		21.7KB	Share
AT1 FY21 Results Investor Briefing
27/08/21		99.35KB	Share
AT1 FY21 Results Presentation
27/08/21	PRICE SENSITIVE	1.94MB	Share
AT1 Appendix 4E & Annual Financial Report
27/08/21	PRICE SENSITIVE	365.91KB	Share
AT1 Ceasing to be a substantial holder
11/08/21		409.53KB	Share
AT1 Investor Briefing - Quarterly Update
30/07/21		124.79KB	Share
AT1 Quarterly Activity Report - 30 June 2021
29/07/21	PRICE SENSITIVE	316.1KB	Share
AT1 Appendix 4C - 30 June 2021
29/07/21	PRICE SENSITIVE	874.74KB	Share
AT1 Change in substantial holding
01/07/21		813.88KB	Share
AT1 Access Bio receives FDA clearance for COVID-19 antibody test
28/06/21	PRICE SENSITIVE	229.77KB	Share
AT1 Proposed issue of Securities - AT1
30/04/21		26.58KB	Share
AT1 Proposed issue of Securities - AT1
30/04/21		26.58KB	Share
AT1 Update to Atomo's US market strategy
30/04/21	PRICE SENSITIVE	154.1KB	Share
AT1 Quarterly Activity Report & Appendix 4C - 31 March 2021
30/04/21	PRICE SENSITIVE	642.38KB	Share
AT1 Viatris & Atomo to Support Unitaid HIV Self-Test Expansion
29/04/21	PRICE SENSITIVE	219.48KB	Share
AT1 Appendix 3Y - C LaBelle
09/04/21		161.43KB	Share
AT1 Cleansing notice
09/04/21		195.72KB	Share
AT1 Appendix 3G
08/04/21		274.49KB	Share
AT1 Appendix 2A
08/04/21		277.68KB	Share
AT1 Atomo to present at NWR Virtual Investor Conference
17/03/21		141.85KB	Share
AT1 S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21	PRICE SENSITIVE	183.24KB	Share
AT1 Investor Presentation
10/03/21		3.21MB	Share
AT1 Notification of release of escrowed shares
08/03/21		136.44KB	Share
AT1 Investor Presentation
23/02/21	PRICE SENSITIVE	2.81MB	Share
AT1 Appendix 4D and Half Year Financial Report
23/02/21	PRICE SENSITIVE	675.53KB	Share
AT1 H1 FY21 results investor briefing
19/02/21		134.79KB	Share
AT1 Quarterly Activity Report & Appendix 4C - 31 December 2020
27/01/21	PRICE SENSITIVE	697.41KB	Share
AT1 Atomo provides update on its HIV Rapid Test business
07/12/20	PRICE SENSITIVE	369.13KB	Share
AT1 Cleansing notice
26/11/20		342.2KB	Share
AT1 Appendix 3G
26/11/20		394.67KB	Share
AT1 Appendix 2A
25/11/20		406.87KB	Share
AT1 Cleansing notice
19/11/20		343KB	Share
AT1 Appendix 2A
18/11/20		406.89KB	Share
AT1 Atomo receives TGA approval for AtomoRapid HIV (1&2) test
10/11/20	PRICE SENSITIVE	355.89KB	Share
AT1 Results of the AGM
04/11/20		350.67KB	Share
AT1 Managing Director's AGM Presentation
04/11/20	PRICE SENSITIVE	1.6MB	Share
AT1 Chairman's AGM Address
04/11/20		330.87KB	Share
AT1 Atomo to present at virtual investor conference
03/11/20		230.16KB	Share
AT1 Cleansing notice
30/10/20		343.56KB	Share
AT1 Appendix 2A
29/10/20		408.31KB	Share
AT1 Quarterly Activity Report & Appendix 4C - 30 September 2020
29/10/20	PRICE SENSITIVE	768.95KB	Share

REFRESH

First 2

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $15.98M

Open	High	Low	Value	Volume
2.6¢	2.6¢	2.4¢	$3.883K	157.7K

Buyers (Bids)

No.	Vol.	Price($)
1	249367	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	140045	1

View Market Depth

No.	Vol.	Price($)
1	249367	0.025
4	145213	0.024
4	850391	0.023
5	588660	0.022
3	194292	0.021

Price($)	Vol.	No.
0.026	140045	1
0.027	355550	3
0.028	55890	2
0.029	425248	5
0.030	417288	8

Last trade - 14.07pm 26/07/2024 (20 minute delay)


Last 2.5¢		Change 0.000 ( 3.85 %)
Open	High	Low	Volume
2.5¢	2.5¢	2.5¢	74545
Last updated 15.51pm 26/07/2024 ?

AT1 (ASX) Chart

ATOMO DIAGNOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available